<< Issue 2, 2009 Podcasts | Podcasts home
The use of cholinesterase inhibitors in people with Alzheimer's disease has long been a focus of interest and concern. In this podcast, Jacqueline Birks, a researcher from Oxford, England, reports the results of an updated systematic review studying the benefits and harms of one of these agents, rivastigmine, including a novel mode of percutaneous administration Play Now! This Podcast also available in:
|
|
|
Bookmark this: 
more ...
|
|
|
 Subscribe with iTunes |
Experiencing technical problems with the podcasts? Tell us! Email: web@cochrane.org
printable